Research Topics
| D A GarciaSummaryAffiliation: University of New Mexico Country: USA Publications
| Collaborators
|
Detail Information
Publications
Update on the diagnosis and management of pulmonary embolismDavid Garcia
Department of Internal Medicine, University of New Mexico, Albuquerque, NM 87131, USA
Br J Haematol 131:301-12. 2005..However, newer treatment options such as low-molecular-weight heparins and the pentasaccharides may offer similar efficacy with improved convenience...- Parenteral Anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesDavid A Garcia
1 University of New Mexico, MSC07 4025, Albuquerque, NM 87131
Chest 141:e24S-43S. 2012..Three additional parenteral direct thrombin inhibitors and danaparoid are approved as alternatives to heparin in patients with HIT... - Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillationDavid A Garcia
Anticoagulation Clinic, University of New Mexico Health Sciences Center, 1 University of New Mexico MSC, 07 4025, Albuquerque, NM 87131, USA
Thromb Res 129:9-16. 2012.... - Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation ForumDavid A Garcia
University of New Mexico School of Medicine, Albuquerque, NM, USA
Ann Pharmacother 42:979-88. 2008.... - Warfarin and pharmacogenomic testing: the case for restraintD A Garcia
Department of Internal Medicine, University of New Mexico, Albuquerque, New Mexico, USA
Clin Pharmacol Ther 84:303-5. 2008 - Duration of anticoagulant therapy for patients with venous thromboembolismDavid Garcia
Internal Medicine, University of New Mexico, MSC10 5550, Albuquerque, NM 87131, USA
Thromb Res 123:S62-4. 2008..This paper will discuss evidence and considerations (including the issue of bleeding risk) that may be relevant to decisions about duration of anticoagulant therapy for patients with VTE... - A prospective, controlled trial of a pharmacy-driven alert system to increase thromboprophylaxis rates in medical inpatientsDavid A Garcia
Division of Hematology Oncology, University of New Mexico School of Medicine, New Mexico, USA
Blood Coagul Fibrinolysis 20:541-5. 2009.... - The new oral anticoagulantsDavid Garcia
University of New Mexico, MSC08 4630, 900 Camino de Salud NE, Albuquerque, NM 87131 0001
Blood 115:15-20. 2010..This review summarizes published clinical trial data pertinent to apixaban, dabigatran, and rivaroxaban... - Current therapeutic strategies and future perspectives for the treatment of venous thromboembolismDavid A Garcia
University of New Mexico, Albuquerque, NM, USA
Curr Pharm Des 16:3475-7. 2010..The chronic management of VTE involves assessment of the risks and benefits of prolonged anticoagulation and is discussed in more detail elsewhere in this issue... - New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugsDavid A Garcia
Department of Internal Medicine, University of New Mexico Health Sciences Center, University of New Mexico, MSC10 5550, Albuquerque, NM 87131, USA
Thromb Haemost 104:1099-105. 2010.... - Thrombosis and malignancy: a case-based reviewDavid Garcia
Division of Hematology Oncology, University of New Mexico Cancer Center, Albuquerque, NM 87131, USA
Semin Hematol 48:259-63. 2011..We will make evidence-based recommendations wherever possible; however, several of the scenarios here were included because pertinent high-quality evidence does not exist... - Reducing the risk for stroke in patients who have atrial fibrillationDavid A Garcia
Department of Internal Medicine, 1 University of New Mexico, MSC10 5550, Albuquerque, NM 87131, USA
Cardiol Clin 26:267-75, vii. 2008.... - Update in the treatment of venous thromboembolismDavid A Garcia
Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131, USA
Semin Respir Crit Care Med 29:40-6. 2008..In addition to presenting evidence relevant to the optimal duration of warfarin therapy, we highlight circumstances under which extended therapy with a parenteral agent such as a low molecular weight heparin might be preferable... - Perioperative anticoagulation for patients with mechanical heart valves: a survey of current practiceDavid A Garcia
Internal Medicine, University of New Mexico, Albuquerque, NM 87131, USA
J Thromb Thrombolysis 18:199-203. 2004..We tested the hypothesis that there is significant practice variation amongst clinicians caring for patients with MHV who require temporary cessation of their warfarin therapy... - Warfarin maintenance dosing patterns in clinical practice: implications for safer anticoagulation in the elderly populationDavid Garcia
Department of Medicine, Division of General Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM, USA
Chest 127:2049-56. 2005.... - Antithrombotic therapy in atrial fibrillationDavid A Garcia
Department of Internal Medicine, University of New Mexico, Albuquerque, NM 87131, USA
Clin Geriatr Med 22:155-66, x. 2006.... - The risk of hemorrhage among patients with warfarin-associated coagulopathyDavid A Garcia
Department of Medicine, University of New Mexico, Albuquerque, New Mexico, USA
J Am Coll Cardiol 47:804-8. 2006..Among warfarin-treated patients with international normalized ratio (INR) >5, we sought to determine the risk of major bleeding within 30 days... - Stroke prevention in elderly patients with atrial fibrillationDavid Garcia
Department of Internal Medicine, University of New Mexico, Albuquerque, NM 87131, USA
Lancet 370:460-1. 2007 - False-negative factor V Leiden genetic testing in a patient with recurrent deep venous thrombosisEdward N Libby
Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico 87131 0001, USA
Am J Hematol 81:284-9. 2006..There is a need for standardization of optimized fVL genetic testing methods. Further education of ordering physicians on the limitations of genetic testing is necessary... - Challenges and benefits of an inpatient anticoagulation service: one hospital's experienceAllison Burnett
Inpatient Pharmacy Department, University of New Mexico Hospital, 2211 Lomas Blvd NE, Albuquerque, NM 87106, USA
J Thromb Thrombolysis 31:344-52. 2011.... - Novel anticoagulants and the future of anticoagulationDavid Garcia
University of New Mexico, Albuquerque, 87131 0001, USA
Thromb Res 123:S50-5. 2009.... - Treatment of venous thromboembolism: guidelines translated for the clinicianM Houman Fekrazad
Division of Hematology Oncology, University of New Mexico, Albuquerque, NM, USA
J Thromb Thrombolysis 28:270-5. 2009..Prevention of postphlebitic syndrome is discussed as well. We will conclude with a brief discussion of future directions including several novel therapeutic anticoagulants... - Cancer-associated thrombosisJohn Winters
Department of Internal Medicine, University of New Mexico School of Medicine, University of New Mexico, Albuquerque, NM 87131, USA
Hematol Oncol Clin North Am 24:695-707, viii. 2010..Outcomes may be improved by an evidence-based approach to management with consideration of practice guidelines... - Perioperative management of anticoagulation: guidelines translated for the clinicianErik P Kraai
University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA
J Thromb Thrombolysis 28:16-22. 2009..We aimed to summarize and provide our opinion about the recommendations from the recent 8th edition of the American College of Chest Physicians (ACCP) guidelines for the perioperative management of antithrombotic therapy... - Risk of thromboembolism with short-term interruption of warfarin therapyDavid A Garcia
Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA
Arch Intern Med 168:63-9. 2008..We aimed to assess the frequency of thromboembolism and bleeding within a large cohort of patients whose warfarin therapy was temporarily withheld for an outpatient invasive procedure... - A survey of oral vitamin K use by anticoagulation clinicsEdward N Libby
University of New Mexico Hospital, Department of Internal Medicine 5ACC, 2211 Lomas NE, Albuquerque, NM 87131, USA
Arch Intern Med 162:1893-6. 2002.... - How we diagnose and treat thrombotic manifestations of the antiphospholipid syndrome: a case-based reviewDavid A Garcia
Department of Internal Medicine, University of New Mexico, Albuquerque, NM, USA
Blood 110:3122-7. 2007..Whenever possible, the recommendations are based on evidence; however, in many cases, insufficient evidence exists, so the recommendation is experiential...